Customizations Possible - Country-wise reports, Additional company profiles, Country/Regional reports and Other Customizations. Special Discounts Available. Global Microbiome Therapeutics Market Size & Trends Report Segmented By Product (FMT, Probiotics, Prebiotics, Small Molecules), Application (GI, Oncology, Infections Diseases, Autoimmune Diseases), Delivery (Oral, Injectable, Topical) & Regional Forecasts to 2029

Global Microbiome Therapeutics Market Size & Trends Report Segmented By Product (FMT, Probiotics, Prebiotics, Small Molecules), Application (GI, Oncology, Infections Diseases, Autoimmune Diseases), Delivery (Oral, Injectable, Topical) & Regional Forecasts to 2029

The global microbiome therapeutics market is set to witness a growth rate of 25-30% in the next 5 years. Increased understanding of the microbiome; rising incidence of chronic diseases; growing trend toward personalized medicine; growing demand for probiotics and prebiotics; increasing R&D investments; and technological advancements in synthetic biology, metagenomics, and microbiome analysis are some of the key factors driving the microbiome therapeutics market. To learn more about the research report, download a sample report.

Report Overview

Microbiome therapeutics refers to the development and use of treatments that aim to modify or restore the human microbiome to improve health and treat diseases. This approach involves targeting the microbial communities in the body, particularly in the gut, to correct imbalances or dysbiosis that contribute to conditions such as gastrointestinal disorders, autoimmune diseases, metabolic disorders, and neurological conditions. Microbiome therapeutics can include probiotics, prebiotics, fecal microbiota transplantation (FMT), and other interventions designed to modulate microbial composition and function, ultimately promoting health and enhancing the body’s natural ability to prevent or manage diseases.

To learn more about the research report, download a sample report.

Increased understanding of the microbiome to propel market demand

The increased understanding of the microbiome is driving the microbiome therapeutics market by revealing its crucial role in various health conditions, such as gastrointestinal disorders, autoimmune diseases, and metabolic disorders. As research advances, it becomes clearer how microbial imbalances or dysbiosis can contribute to disease, fueling demand for therapies that restore or modulate the microbiome. This knowledge is encouraging the development of targeted treatments, such as probiotics, prebiotics, and fecal microbiota transplants, to correct these imbalances. The growing recognition of the microbiome’s influence on overall health is expanding therapeutic possibilities, creating significant market growth opportunities.

To learn more about the research report, download a sample report.

Rising incidence of chronic diseases is driving the market growth

The rising incidence of chronic diseases, such as inflammatory bowel disease (IBD), diabetes, obesity, and autoimmune disorders, is driving the microbiome therapeutics market by highlighting the need for innovative treatments. Research has shown that imbalances in the microbiome are linked to these conditions, prompting the development of microbiome-based therapies to address the root causes. As these diseases become more prevalent, there is growing interest in therapies that can modulate the microbiome to prevent or manage chronic diseases. This trend is fueling the demand for probiotics, prebiotics, and other microbiome interventions, thereby accelerating market growth and development.

Competitive Market Analysis

The global microbiome therapeutics market is marked by the presence of established and emerging market players such as Seres Therapeutics, Ferring Pharmaceuticals, BiomeBank, Pendulum, Seed Health, Inc., Biohm, Actial Farmaceutica Srl, OptiBiotix Health Plc and ExeGi Pharma; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Report Scope

Report Scope	Details
Base Year Considered	2023
Historical Data	2022 - 2023
Forecast Period	2024 - 2029
Market Drivers	Increased understanding of the microbiome Rising incidence of chronic diseases Growing trend toward personalized medicine Growing demand for probiotics and prebiotics
Attractive Opportunities	Exploring new therapeutic areas Growing partnerships and collaborations Microbiome diagnostics Cosmetic and skin care applications
Segment Scope	Product, Application, Mode of Delivery
Regional Scope	North America (US & Canada) Europe (UK, Germany, France, Italy, Spain, Rest of Europe) Asia Pacific (China, India, Japan, Rest of Asia Pacific) Latin America Middle East & Africa
Key Companies Mapped	Seres Therapeutics, Ferring Pharmaceuticals, BiomeBank, Pendulum, Seed Health, Inc., Biohm, Actial Farmaceutica Srl, OptiBiotix Health Plc and ExeGi Pharma. among others
Report Highlights	Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis

Market Segmentation

This report by Medi-Tech Insights provides the size of the global microbiome therapeutics market at the regional- and country-level from 2022 to 2029. The report further segments the market based on product, application, and mode of delivery.

Market Size & Forecast (2022-2029), By Product, USD Million
- Probiotics
- Prebiotics
- Fecal Microbiota Transplantation (FMT)
- Postbiotics
- Small Molecules
- Others
Market Size & Forecast (2022-2029), By Application, USD Million
- Gastrointestinal Disorders
- Oncology
- Endocrine and Metabolic Disorders
- Autoimmune Diseases
- Infectious Diseases
- Others
Market Size & Forecast (2022-2029), By Mode of Delivery, USD Million
- Oral Delivery
- Injectables
- Topical
- Others
Market Size & Forecast (2022-2029), By Region, USD Million
- North America
  - US
  - Canada
- Europe
  - UK
  - Germany
  - France
  - Italy
  - Spain
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Rest of Asia Pacific
- Latin America
- Middle East & Africa

Key Strategic Questions Addressed

What is the market size & forecast of the microbiome therapeutics market?
What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the microbiome therapeutics market?
What are the key trends defining the market?
What are the major factors impacting the market?
What are the opportunities prevailing in the market?
Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
Who are the major players operating in the market?
What are the key strategies adopted by players?

Introduction
- Introduction
- Market Scope
  - Market Definition
  - Segments Covered
  - Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2023-2024)
Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
  - Bottom-Up Approach
  - Top-Down Approach
- Market Forecasting
Executive Summary
- Microbiome Therapeutics Market Snapshot (2023-2029)
- Segment Overview
- Regional Snapshot
- Competitive Insights
Market Overview
- Market Dynamics
- Drivers
  - Increased understanding of the microbiome
  - Rising incidence of chronic diseases
  - Growing trend toward personalized medicine
  - Growing demand for probiotics and prebiotics
  - Increasing R&D investments
  - Technological advancements in synthetic biology, metagenomics, and microbiome analysis
- Restraints
  - Regulatory challenges
  - Safety concerns regarding microbiome therapeutics
  - High R&D costs associated with development of microbiome-based therapies
  - Limited awareness and acceptance of microbiome therapeutics
- Opportunities
  - Exploring new therapeutic areas
  - Growing partnerships and collaborations
  - Microbiome diagnostics
  - Cosmetic and skin care applications
- Key Market Trends
  - Microbiome-based cancer immunotherapy
  - Expansion beyond gastrointestinal disorders
- Unmet Market Needs
- Industry Speaks
- Regulatory Analysis
Global Microbiome Therapeutics Market Size & Forecast (2022-2029), By Product, USD Million
- Introduction
- Probiotics
- Prebiotics
- Fecal Microbiota Transplantation (FMT)
- Postbiotics
- Small Molecules
- Others
Global Microbiome Therapeutics Market Size & Forecast (2022-2029), By Application, USD Million
- Introduction
- Gastrointestinal Disorders
- Oncology
- Endocrine and Metabolic Disorders
- Autoimmune Diseases
- Infectious Diseases
- Others
Global Microbiome Therapeutics Market Size & Forecast (2022-2029), By Mode of Delivery, USD Million
- Introduction
- Oral Delivery
- Injectables
- Topical
- Others
Global Microbiome Therapeutics Market Size & Forecast (2022-2029), By Region, USD Million
- Introduction
- North America Microbiome Therapeutics Market Size & Forecast (2022-2029), By Country, USD Million
  - US
    - Market Size & Forecast, By Product (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By Mode of Delivery (USD Million)
  - Canada
    - Market Size & Forecast, By Product (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By Mode of Delivery (USD Million)
- Europe Microbiome Therapeutics Market Size & Forecast (2022-2029), By Country, USD Million
  - UK
    - Market Size & Forecast, By Product (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By Mode of Delivery (USD Million)
  - Germany
    - Market Size & Forecast, By Product (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By Mode of Delivery (USD Million)
  - France
    - Market Size & Forecast, By Product (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By Mode of Delivery (USD Million)
  - Italy
    - Market Size & Forecast, By Product (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By Mode of Delivery (USD Million)
  - Spain
    - Market Size & Forecast, By Product (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By Mode of Delivery (USD Million)
  - Rest of Europe
    - Market Size & Forecast, By Product (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By Mode of Delivery (USD Million)
- Asia Pacific (APAC) Microbiome Therapeutics Market Size & Forecast (2022-2029), By Country, USD Million
  - China
    - Market Size & Forecast, By Product (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By Mode of Delivery (USD Million)
  - Japan
    - Market Size & Forecast, By Product (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By Mode of Delivery (USD Million)
  - India
    - Market Size & Forecast, By Product (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By Mode of Delivery (USD Million)
  - Rest of Asia Pacific
    - Market Size & Forecast, By Product (USD Million)
    - Market Size & Forecast, By Application (USD Million)
    - Market Size & Forecast, By Mode of Delivery (USD Million)
- Latin America (LATAM) Microbiome Therapeutics Market Size & Forecast (2022-2029), USD Million
  - Market Size & Forecast, By Product (USD Million)
  - Market Size & Forecast, By Application (USD Million)
  - Market Size & Forecast, By Mode of Delivery (USD Million)
- Middle East & Africa (MEA) Microbiome Therapeutics Market Size & Forecast (2022-2029), USD Million
  - Market Size & Forecast, By Product (USD Million)
  - Market Size & Forecast, By Application (USD Million)
  - Market Size & Forecast, By Mode of Delivery (USD Million)
Competitive Landscape
- Key Players and their Competitive Positioning
  - Key Player Comparison
  - Segment-wise Player Mapping
  - Market Share Analysis (2023)
  - Company Categorization Matrix
    - Dominants/Leaders
    - New Entrants
    - Emerging Players
    - Innovative Players
  - Key Strategies Assessment, By Player (2022-2024)
    - New Product Launches
    - Partnerships, Agreements, & Collaborations
    - Mergers & Acquisitions
    - Geographic Expansion
Company Profiles*(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Seres Therapeutics
- Ferring Pharmaceuticals
- BiomeBank
- Pendulum
- Seed Health, Inc.
- Biohm
- Actial Farmaceutica Srl
- OptiBiotix Health Plc.
- ExeGi Pharma
- Other Prominent Players

Note: *Indicative list

**For listed companies

Research Methodology

The study has been compiled based on extensive primary and secondary research.

Secondary Research (Indicative List)

Primary Research

To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.

Supply Side Stakeholders:

Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants

Demand Side Stakeholders:

Stakeholders from Hospitals and Clinics (Physicians, Gastroenterologists, Dermatologists, and Other Specialists); Pharmacies and Retail Stores; Academic and Research Institutions; and Others

Breakdown of Primary Interviews

Market Size Estimation

Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts

Data Triangulation

Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data

To learn more about the research report, download a sample report.

Global Microbiome Therapeutics Market Size & Trends Report Segmented By Product (FMT, Probiotics, Prebiotics, Small Molecules), Application (GI, Oncology, Infections Diseases, Autoimmune Diseases), Delivery (Oral, Injectable, Topical) & Regional Forecasts to 2029

Report Overview

Competitive Market Analysis

Report Scope

Market Segmentation

Secondary Research (Indicative List)

Primary Research

Market Size Estimation

Data Triangulation

Quick Enquiry Form